MARKET NEWS AND UPDATES.
Get notified for Latest News and Market Alerts.
Get notified for Latest News and Market Alerts.
×
CMP as on 05-Jul-22 15:29
₹ 1,453.90Open
₹ 1,440.00Turnover (lac)
₹ 4,310Prev. Close
₹ 1,431.50Day's Vol (shares)
₹ 2,96,464CMP as on05-Jul-22 15:29
₹ 1,450.30Open
₹ 1,455.00Turnover (lac)
₹ 92Prev. Close
₹ 1,429.90Day's Vol (shares)
₹ 3,608CMP as on 05-Jul-22 15:29
₹ 1,449.00Open
₹ 1,451.80Open Interest(Contracts)
₹ 9,93,300VWAP
₹ 1,449.52Day's Vol (shares)
₹ 2,56,500Promoters have no intention to exit the business and are in fact focused on strengthening the Metropolis Brand, said company.
The medical diagnostic chain on Monday clarified that its promoters have no intention to exit the business.
EBITDA for FY22 stood at Rs361.60 crore, registering a growth of 20% yoy against Rs301.30 crore in the previous financial year.
Acrysil Ltd, Dr Lal Pathlabs Ltd, Paushak Ltd and Delta Corp Ltd are among the other losers in the BSEs A group today, 18 May 2022.
On 24 May 2022
Metropolis Healthcare reported 30% fall in consolidated net profit to Rs 41.2 crore despite a 7% rise in total revenue from operations
Of Rs.8 per share
Sales rise 6.65% to Rs 293.05 crore
On 11 February 2022
Metropolis has initially launched this program in 2018 to support and nurture medical students so that they can contribute their best t
Per Order for ETF & Mutual Funds Brokerage
Per Order for Delivery, Intraday, F&O, Currency & Commodity
